nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—Ileus paralytic—Vincristine—lymphatic system cancer	0.0191	0.0191	CcSEcCtD
Amoxapine—Numbness—Fludarabine—lymphatic system cancer	0.0163	0.0163	CcSEcCtD
Amoxapine—Sensory loss—Fludarabine—lymphatic system cancer	0.0156	0.0156	CcSEcCtD
Amoxapine—Inappropriate antidiuretic hormone secretion—Vincristine—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Amoxapine—Jaundice—Mechlorethamine—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Amoxapine—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Amoxapine—Cerebrovascular accident—Fludarabine—lymphatic system cancer	0.01	0.01	CcSEcCtD
Amoxapine—Numbness—Vincristine—lymphatic system cancer	0.00995	0.00995	CcSEcCtD
Amoxapine—Petechiae—Mitoxantrone—lymphatic system cancer	0.00976	0.00976	CcSEcCtD
Amoxapine—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00975	0.00975	CcSEcCtD
Amoxapine—Sensory loss—Vincristine—lymphatic system cancer	0.00952	0.00952	CcSEcCtD
Amoxapine—Alopecia—Mechlorethamine—lymphatic system cancer	0.00924	0.00924	CcSEcCtD
Amoxapine—Coordination abnormal—Carmustine—lymphatic system cancer	0.0088	0.0088	CcSEcCtD
Amoxapine—Stomatitis—Teniposide—lymphatic system cancer	0.00837	0.00837	CcSEcCtD
Amoxapine—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00815	0.00815	CcSEcCtD
Amoxapine—Disorientation—Bleomycin—lymphatic system cancer	0.00803	0.00803	CcSEcCtD
Amoxapine—Gynaecomastia—Carmustine—lymphatic system cancer	0.00773	0.00773	CcSEcCtD
Amoxapine—Mental disability—Carmustine—lymphatic system cancer	0.0075	0.0075	CcSEcCtD
Amoxapine—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.00744	0.00744	CcSEcCtD
Amoxapine—Myocardial infarction—Fludarabine—lymphatic system cancer	0.0074	0.0074	CcSEcCtD
Amoxapine—Stomatitis—Fludarabine—lymphatic system cancer	0.00736	0.00736	CcSEcCtD
Amoxapine—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.00733	0.00733	CcSEcCtD
Amoxapine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00728	0.00728	CcSEcCtD
Amoxapine—Anorexia—Mechlorethamine—lymphatic system cancer	0.00708	0.00708	CcSEcCtD
Amoxapine—Alopecia—Teniposide—lymphatic system cancer	0.00681	0.00681	CcSEcCtD
Amoxapine—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00674	0.00674	CcSEcCtD
Amoxapine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00646	0.00646	CcSEcCtD
Amoxapine—Agitation—Teniposide—lymphatic system cancer	0.00617	0.00617	CcSEcCtD
Amoxapine—Leukopenia—Teniposide—lymphatic system cancer	0.00601	0.00601	CcSEcCtD
Amoxapine—Alopecia—Fludarabine—lymphatic system cancer	0.00599	0.00599	CcSEcCtD
Amoxapine—Ataxia—Carmustine—lymphatic system cancer	0.0059	0.0059	CcSEcCtD
Amoxapine—Hypertension—Teniposide—lymphatic system cancer	0.0058	0.0058	CcSEcCtD
Amoxapine—Urinary retention—Vincristine—lymphatic system cancer	0.00569	0.00569	CcSEcCtD
Amoxapine—Ataxia—Vincristine—lymphatic system cancer	0.00563	0.00563	CcSEcCtD
Amoxapine—Confusional state—Teniposide—lymphatic system cancer	0.00552	0.00552	CcSEcCtD
Amoxapine—Oedema—Teniposide—lymphatic system cancer	0.00548	0.00548	CcSEcCtD
Amoxapine—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00546	0.00546	CcSEcCtD
Amoxapine—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00543	0.00543	CcSEcCtD
Amoxapine—Agitation—Fludarabine—lymphatic system cancer	0.00542	0.00542	CcSEcCtD
Amoxapine—Stomatitis—Bleomycin—lymphatic system cancer	0.0054	0.0054	CcSEcCtD
Amoxapine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00536	0.00536	CcSEcCtD
Amoxapine—Tachycardia—Teniposide—lymphatic system cancer	0.00535	0.00535	CcSEcCtD
Amoxapine—Leukopenia—Fludarabine—lymphatic system cancer	0.00528	0.00528	CcSEcCtD
Amoxapine—Pruritus—Mechlorethamine—lymphatic system cancer	0.00526	0.00526	CcSEcCtD
Amoxapine—Anorexia—Teniposide—lymphatic system cancer	0.00522	0.00522	CcSEcCtD
Amoxapine—Hypotension—Teniposide—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Amoxapine—Convulsion—Fludarabine—lymphatic system cancer	0.00511	0.00511	CcSEcCtD
Amoxapine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Amoxapine—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00494	0.00494	CcSEcCtD
Amoxapine—Petechiae—Methotrexate—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Amoxapine—Confusional state—Fludarabine—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Amoxapine—Oedema—Fludarabine—lymphatic system cancer	0.00482	0.00482	CcSEcCtD
Amoxapine—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Amoxapine—Decreased appetite—Teniposide—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Amoxapine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Amoxapine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00471	0.00471	CcSEcCtD
Amoxapine—Stomatitis—Carmustine—lymphatic system cancer	0.00471	0.00471	CcSEcCtD
Amoxapine—Rash—Mechlorethamine—lymphatic system cancer	0.00469	0.00469	CcSEcCtD
Amoxapine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00468	0.00468	CcSEcCtD
Amoxapine—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00464	0.00464	CcSEcCtD
Amoxapine—Anorexia—Fludarabine—lymphatic system cancer	0.00459	0.00459	CcSEcCtD
Amoxapine—Weight increased—Mitoxantrone—lymphatic system cancer	0.00459	0.00459	CcSEcCtD
Amoxapine—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Amoxapine—Myocardial infarction—Vincristine—lymphatic system cancer	0.00452	0.00452	CcSEcCtD
Amoxapine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Amoxapine—Stomatitis—Vincristine—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Amoxapine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Amoxapine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Amoxapine—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00443	0.00443	CcSEcCtD
Amoxapine—Nausea—Mechlorethamine—lymphatic system cancer	0.00441	0.00441	CcSEcCtD
Amoxapine—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Amoxapine—Alopecia—Bleomycin—lymphatic system cancer	0.00439	0.00439	CcSEcCtD
Amoxapine—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00438	0.00438	CcSEcCtD
Amoxapine—Jaundice—Mitoxantrone—lymphatic system cancer	0.00438	0.00438	CcSEcCtD
Amoxapine—Urticaria—Teniposide—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Amoxapine—Abdominal pain—Teniposide—lymphatic system cancer	0.00433	0.00433	CcSEcCtD
Amoxapine—Body temperature increased—Teniposide—lymphatic system cancer	0.00433	0.00433	CcSEcCtD
Amoxapine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Amoxapine—Hallucination—Carmustine—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Amoxapine—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Amoxapine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00424	0.00424	CcSEcCtD
Amoxapine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Amoxapine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Amoxapine—Fatigue—Fludarabine—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Amoxapine—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Amoxapine—Hallucination—Vincristine—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Amoxapine—Constipation—Fludarabine—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Amoxapine—Vasculitis—Methotrexate—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Amoxapine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Amoxapine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Amoxapine—Asthenia—Teniposide—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Amoxapine—Pruritus—Teniposide—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Amoxapine—Leukopenia—Bleomycin—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Amoxapine—Alopecia—Carmustine—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Amoxapine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Amoxapine—Diarrhoea—Teniposide—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Amoxapine—Alopecia—Vincristine—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Amoxapine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Amoxapine—Alopecia—Mitoxantrone—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Amoxapine—Confusional state—Bleomycin—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Amoxapine—Vision blurred—Carmustine—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Amoxapine—Tremor—Carmustine—lymphatic system cancer	0.00354	0.00354	CcSEcCtD
Amoxapine—Oedema—Bleomycin—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Amoxapine—Vomiting—Teniposide—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Amoxapine—Agitation—Carmustine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Amoxapine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Amoxapine—Asthenia—Fludarabine—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Amoxapine—Rash—Teniposide—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Amoxapine—Dermatitis—Teniposide—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Amoxapine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Amoxapine—Headache—Teniposide—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Amoxapine—Pruritus—Fludarabine—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Amoxapine—Leukopenia—Carmustine—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Amoxapine—Anorexia—Bleomycin—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Amoxapine—Agitation—Vincristine—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Amoxapine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Amoxapine—Hypotension—Bleomycin—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Amoxapine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Amoxapine—Convulsion—Carmustine—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Amoxapine—Hypertension—Carmustine—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Amoxapine—Nausea—Teniposide—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Amoxapine—Leukopenia—Vincristine—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Amoxapine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Amoxapine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Amoxapine—Convulsion—Vincristine—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Amoxapine—Hypertension—Vincristine—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Amoxapine—Confusional state—Carmustine—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Amoxapine—Oedema—Carmustine—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Amoxapine—Decreased appetite—Bleomycin—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Amoxapine—Vomiting—Fludarabine—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Amoxapine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Amoxapine—Rash—Fludarabine—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Amoxapine—Dermatitis—Fludarabine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Amoxapine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Amoxapine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Amoxapine—Headache—Fludarabine—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Amoxapine—Tachycardia—Carmustine—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Amoxapine—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Amoxapine—Oedema—Vincristine—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Amoxapine—Anorexia—Carmustine—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Amoxapine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Amoxapine—Confusional state—Mitoxantrone—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Amoxapine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Amoxapine—Hypotension—Carmustine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Amoxapine—Oedema—Mitoxantrone—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Amoxapine—Nausea—Fludarabine—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Amoxapine—Shock—Mitoxantrone—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Amoxapine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Amoxapine—Urticaria—Bleomycin—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Amoxapine—Anorexia—Vincristine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Amoxapine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Amoxapine—Body temperature increased—Bleomycin—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Amoxapine—Insomnia—Carmustine—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Amoxapine—Paraesthesia—Carmustine—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Amoxapine—Hypotension—Vincristine—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Amoxapine—Somnolence—Carmustine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Amoxapine—Anorexia—Mitoxantrone—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Amoxapine—Ataxia—Methotrexate—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Amoxapine—Decreased appetite—Carmustine—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Amoxapine—Hypotension—Mitoxantrone—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Amoxapine—Insomnia—Vincristine—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Amoxapine—Paraesthesia—Vincristine—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Amoxapine—Constipation—Carmustine—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Amoxapine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Amoxapine—Decreased appetite—Vincristine—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Amoxapine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Amoxapine—Feeling abnormal—Carmustine—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Amoxapine—Fatigue—Vincristine—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Amoxapine—Asthenia—Bleomycin—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Amoxapine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Amoxapine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Amoxapine—Constipation—Vincristine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Amoxapine—Pruritus—Bleomycin—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Amoxapine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Amoxapine—Eosinophilia—Methotrexate—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Amoxapine—Fatigue—Mitoxantrone—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Amoxapine—Pancreatitis—Methotrexate—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Amoxapine—Constipation—Mitoxantrone—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Amoxapine—Abdominal pain—Carmustine—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Amoxapine—Body temperature increased—Carmustine—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Amoxapine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Amoxapine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Amoxapine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Amoxapine—Abdominal pain—Vincristine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Amoxapine—Body temperature increased—Vincristine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Amoxapine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Amoxapine—Urticaria—Mitoxantrone—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Amoxapine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Amoxapine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Amoxapine—Vomiting—Bleomycin—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Amoxapine—Drowsiness—Methotrexate—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Amoxapine—Rash—Bleomycin—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Amoxapine—Dermatitis—Bleomycin—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Amoxapine—Asthenia—Carmustine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Amoxapine—Stomatitis—Methotrexate—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Amoxapine—Asthenia—Vincristine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Amoxapine—Diarrhoea—Carmustine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Amoxapine—Nausea—Bleomycin—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Amoxapine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Amoxapine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Amoxapine—Dizziness—Carmustine—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Amoxapine—Diarrhoea—Vincristine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Amoxapine—Hepatitis—Methotrexate—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Amoxapine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Amoxapine—Vomiting—Carmustine—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Amoxapine—Dizziness—Vincristine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Amoxapine—Rash—Carmustine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Amoxapine—Dermatitis—Carmustine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Amoxapine—Headache—Carmustine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Amoxapine—Tinnitus—Methotrexate—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Amoxapine—Vomiting—Vincristine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Amoxapine—Rash—Vincristine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Amoxapine—Dermatitis—Vincristine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Amoxapine—Headache—Vincristine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Amoxapine—Nausea—Carmustine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Amoxapine—Vomiting—Mitoxantrone—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Amoxapine—Rash—Mitoxantrone—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Amoxapine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Amoxapine—Headache—Mitoxantrone—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Amoxapine—Alopecia—Methotrexate—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Amoxapine—Nausea—Vincristine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Amoxapine—Dysgeusia—Methotrexate—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Amoxapine—Nausea—Mitoxantrone—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Amoxapine—Vision blurred—Methotrexate—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Amoxapine—Leukopenia—Methotrexate—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Amoxapine—Convulsion—Methotrexate—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Amoxapine—Confusional state—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Amoxapine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Amoxapine—Anorexia—Methotrexate—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Amoxapine—Hypotension—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Amoxapine—Insomnia—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Amoxapine—Paraesthesia—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Amoxapine—Somnolence—Methotrexate—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Amoxapine—Dyspepsia—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Amoxapine—Decreased appetite—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Amoxapine—Fatigue—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Amoxapine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Amoxapine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Amoxapine—Urticaria—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Amoxapine—Abdominal pain—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Amoxapine—Body temperature increased—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Amoxapine—Asthenia—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Amoxapine—Pruritus—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Amoxapine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000977	0.000977	CcSEcCtD
Amoxapine—Dizziness—Methotrexate—lymphatic system cancer	0.000944	0.000944	CcSEcCtD
Amoxapine—Vomiting—Methotrexate—lymphatic system cancer	0.000908	0.000908	CcSEcCtD
Amoxapine—Rash—Methotrexate—lymphatic system cancer	0.0009	0.0009	CcSEcCtD
Amoxapine—Dermatitis—Methotrexate—lymphatic system cancer	0.000899	0.000899	CcSEcCtD
Amoxapine—Headache—Methotrexate—lymphatic system cancer	0.000894	0.000894	CcSEcCtD
Amoxapine—Nausea—Methotrexate—lymphatic system cancer	0.000848	0.000848	CcSEcCtD
